SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 10, 2022
GUARDION HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
15150 Avenue of Science, Suite 200
San Diego, CA 92128
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (858) 605-9055
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|Common Stock, par value $0.001 per share||GHSI||The Nasdaq Stock Market LLC|
Emerging growth company ☒
|Item 7.01||Regulation FD Disclosure|
On January 10, 2022, Guardion Health Sciences, Inc. (the “Company”) will make a presentation (the “Presentation”) at the H.C. Wainwright Bioconnect 2022 Virtual Conference. The Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
|Item 9.01||Financial Statements and Exhibits|
|99.1||PowerPoint Presentation, dated January 2022|
|104||Inline XBRL for the cover page of this Current Report on Form 8-K|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|GUARDION HEALTH SCIENCES, INC.|
|Date: January 10, 2022|
|By:||/s/ Bret Scholtes|
|Title:||Chief Executive Officer|